On Tuesday, Elanco Animal Health Incorporated (NYSE:ELAN) used its first Investor Day in five years to signal a turning point for the company, outlining a more focused strategy aimed at sustainable growth, margin expansion, and a stronger balance sheet.CEO Jeff Simmons said the company is entering a new phase built on consistent execution of its Innovation, Portfolio, and Productivity framework, with a clear goal of becoming a reliable mid-single-digit organic grower with expanding profitability.Financial O ...